(Q50128234)

25 February 2018

title

Effect of pre-existing carrier immunity on the efficacy of synthetic influenza vaccine (English)

1 reference

25 February 2018

1 reference

Ben-Yedidia T

1

1 reference

25 February 2018

Arnon R

series ordinal

2

1 reference

25 February 2018

publication date

1 November 1998

1 reference

25 February 2018

published in

immunology Letters

1 reference

25 February 2018

volume

64

1 reference

25 February 2018

issue

1

1 reference

25 February 2018

page(s)

9-15

1 reference

25 February 2018

Towards vaccine optimisation

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Epitope-Specific Regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Effect of neonatal immunization with diphtheria and tetanus toxoids on antibody responses to Haemophilus influenzae type b conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Carrier-induced epitope-specific regulation and its bypass in a protein-protein conjugate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Effect of carrier on the immunogenic capacity of synthetic cholera vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Modulation of carrier-induced epitopic suppression by Bordetella pertussis components and muramyl peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Use of Prior Vaccinations for the Development of New Vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Epitopic suppression in synthetic vaccine models: analysis of the effector mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Synthetic recombinant influenza vaccine induces efficient long-term immunity and cross-strain protection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Immune response to cholera toxin epitope inserted in Salmonella flagellin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Method for the isolation of highly purified Salmonella flagellins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

Efficacy of anti-influenza peptide vaccine in aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-2478%2898%2900073-X

7 January 2021

10.1016/S0165-2478(98)00073-X

Identifiers

DOI

1 reference

25 February 2018

1 reference

25 February 2018